Metrikler
Yayın
250
Açık Erişim
42
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
2015 - 2017
2015 - 2017Yüksek Lisans
Hacettepe Üniversitesi, Kanser Enstitüsü, Prevantif Onkoloji Ad, Türkiye
2005 - 2009
2005 - 2009Tıpta Yandal Uzmanlık
Hacettepe Üniversitesi, Tıp Fakültesi, İç Hastalıkları Abd Medikal Onkoloji Bölümü, Türkiye
2000 - 2005
2000 - 2005Tıpta Uzmanlık
Hacettepe Üniversitesi, Tıp Fakültesi, İç Hastalıkları Abd, Türkiye
1994 - 2000
1994 - 2000Lisans
Hacettepe Üniversitesi, Tıp Fakültesi (İng), Türkiye
Yaptığı Tezler
2017
2017Yüksek Lisans
Kronik periodontiti olan hastalarda kanser insidansının değerlendirilmesi
Hacettepe Üniversitesi, Kanser Enstitüsü, Prevantif Onkoloji Ad
2009
2009Tıpta Uzmanlık
Aromataz inhibitörü kullanan meme kanserli hastalarda artralji sıklığı ve patogenezinin araştırılması 
Hacettepe Üniversitesi, Tıp Fakültesi, İç Hastalıkları Ad Tıbbi Onkoloji Bölümü
2005
2005Tıpta Uzmanlık
Multiple myelomalı hastalarda kemik tutulumunun belirlenmesinde kemik rezorbsiyon belirteçlerinin rolü
Hacettepe Üniversitesi, Tıp Fakültesi, İç Hastalıkları Ad
Yabancı Diller
C1 İleri
C1 İleriİngilizce
Araştırma Alanları
Tıp
Sağlık Bilimleri
Dahili Tıp Bilimleri
İç Hastalıkları
Onkoloji
Akademik Faaliyetlere Dayalı Araştırma Alanları
Avesis Araştırma Alanları
WoS Araştırma Alanları
Scopus Araştırma Alanları
Akademik Ünvanlar / Görevler
2017 - Devam Ediyor
2017 - Devam EdiyorProf. Dr.
Hacettepe Üniversitesi, Kanser Enstitüsü, Prevantif Onkoloji Ad
Yönetimsel Görevler
2016 - Devam Ediyor
2016 - Devam EdiyorBaşhekim
Hacettepe Üniversitesi
Akademi Dışı Deneyim
2009 - 2011
2009 - 2011Uzman Dr
SAĞLIK BAKANLIĞI Ankara Atatürk Eğitim Araştırma Hastanesi Tıbbi Onkoloji, Uzman Dr
Yönetilen Tezler
2018
2018Yüksek Lisans
Kanser tanısı alan hastaların birinci dereceden yakınlarında sigara bırakma davranışının değerlendirilmesi
DİZDAR Ö.
B.HÜSEYİN(Öğrenci)
2017
2017Tıpta Uzmanlık
Kolorektal kanser tanısı alan premenopozal kadınlarda adjuvan kemoterapiye bağlı amenore sıklığı ve ilişkili faktörlerin belirlenmesi
DİZDAR Ö.
T.ŞAHİN(Öğrenci)
Makaleler
Tümü (197)
SCI-E, SSCI, AHCI (184)
SCI-E, SSCI, AHCI, ESCI (190)
ESCI (5)
Scopus (190)
TRDizin (17)
2025
20251. Prognostic value of the body composition parameters in patients with colorectal liver metastases undergoing intra-arterial treatment
Ozbay Y., ELDEM F. G., ÇAY F., BOZKURT M. F., Salanci B., Ormanci A., et al.
EXPERT REVIEW OF ANTICANCER THERAPY
, 2025 (SCI-Expanded, Scopus)
2025
20252. Incidence of Unexpected Lymph Node Positivity and Its Prognostic Impact in Patients Undergoing Pulmonary Metastasectomy
Kumbasar U., DİZDAR Ö., Uysal S., Yilmaz Y., Aydar I., KAŞIKCI ÇAVDAR M., et al.
INDIAN JOURNAL OF SURGERY
, 2025 (SCI-Expanded, Scopus)
2025
20253. Adjuvant Gemcitabine-cisplatin Combination for Biliary Tract Cancer: A Real Life Experience
Kuş F., Yildirim H. c., Akyildiz A., Tatar O. D., Ozmen A., Sirvan F., et al.
Acta haematologica oncologica Turcica
, cilt.58, sa.2, ss.121-126, 2025 (TRDizin)
2025
20254. Breast Radiotherapy: A Potential Risk Factor for Resistant Clone Development in Patients with Brain Metastasis
Yildirim H. c., Kavgacı G., Evlendi Y., CHALABIYEV E., Guven D. C., Dizdar O., et al.
Journal of oncological sciences
, cilt.11, sa.1, ss.7-13, 2025 (TRDizin)
2025
20255. Clinical Characteristics and Management of Patients Admitted to the Supportive Care Clinic and Predisposing Factors of Unplanned Hospital Readmission: Single-Center Experience
BAŞ O., Tokatli M., Guduk N., Erdogan D., Boyraz N. E., Cengelci C., et al.
JOURNAL OF CLINICAL MEDICINE
, sa.8, 2025 (SCI-Expanded, Scopus)
2025
20256. The association between blood sodium levels and survival in patients treated with immune checkpoint inhibitors
ŞAHİN T. K., GÜVEN D. C., Durukan M., KAVGACI G., KAYGUSUZ Y., ARIK Z., et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
, sa.4, ss.129-137, 2025 (SCI-Expanded)
2025
20257. Artificial Intelligence (ChatGPT-4o) in Adjuvant Treatment Decision-Making for Stage II Colon Cancer: A Comparative Analysis with Clinician Recommendations and NCCN/ESMO Guidelines
KUŞ F., Chalabiyev E., YILDIRIM H. Ç., Koc Kus I., ŞİRVAN F., DİZDAR Ö., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.35, sa.1, ss.68-74, 2025 (SCI-Expanded, Scopus, TRDizin)
2025
20258. Serum Albumin-Creatinine Ratio and Anthracycline Cardiotoxicity in Patients with Cancer
BAŞ O., Guduk N., Tokatli M., Guven D. C., ÖZER N., ŞENER Y. Z., et al.
JOURNAL OF CLINICAL MEDICINE
, sa.5, 2025 (SCI-Expanded, Scopus)
2025
20259. Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study
Majidova N., Arak H., ÖZALP F. R., BAŞ O., ÖZÇELİK KÖKER G., Ozmarasali E. B., et al.
SCIENTIFIC REPORTS
, sa.1, 2025 (SCI-Expanded, Scopus)
2025
202510. The association between HALP score and survival in patients treated with immune checkpoint inhibitors
ŞAHİN T. K., GÜVEN D. C., Durukan M., BAŞ O., KAYGUSUZ Y., ARIK Z., et al.
EXPERT REVIEW OF ANTICANCER THERAPY
, sa.1, ss.81-89, 2025 (SCI-Expanded)
2024
202411. PD-L1 Expression for Tailoring Treatment in Advanced Melanoma-It Is Never That Easy
Karahan L., HAYRAN K. M., DİZDAR Ö.
JAMA ONCOLOGY
, sa.12, ss.1733, 2024 (SCI-Expanded, Scopus)
2024
202412. Sorafenib vs chemotherapy in the treatment of locally advanced or metastatic, radioactive iodine-refractory differentiated thyroid cancer: real-world data from Turkey
Majidova N., Aghamaliyeva S., Guliyev M., Dinc G., AKYILDIZ A., Ozcan E., et al.
JOURNAL OF CHEMOTHERAPY
, 2024 (SCI-Expanded, Scopus)
2024
202413. Cancer chemotherapy: incidence and predictors of 30-day mortality
DİZDAR Ö., DEMİR M., BOZBULUT U. B., HAYRAN K. M., Kars A.
BMJ SUPPORTIVE & PALLIATIVE CARE
, sa.E2, 2024 (SCI-Expanded, Scopus)
2024
202414. Rituximab-induced leukocytoclastic vasculitis in a patient with low-grade orbital B-cell lymphoma: a case report
Guener N. I., DİZDAR Ö., Tuerker A., EKİNCİOĞLU A.
ANTI-CANCER DRUGS
, cilt.35, sa.9, ss.878-881, 2024 (SCI-Expanded, Scopus)
2024
202415. The effect of an empowerment program on ruminative thoughts, fatigue and psychological resilience of cancer survivors: A randomized controlled trial
Ocalan S., Uzar-Ozcetin S. Y., Dizdar O., Gurel C. S.
ANNALS OF ONCOLOGY
, 2024 (SCI-Expanded, Scopus)
2024
202416. Sexual dysfunction and quality of life in rectal cancer
Kus F., Yildirim H. C., Guven D. C., Chalabiyev E., Sirvan F., Dizdar O., et al.
ANNALS OF ONCOLOGY
, 2024 (SCI-Expanded, Scopus)
2024
202417. An Institutional Febrile Neutropenia Protocol Improved the Antibacterial Treatment and Encouraged the Development of a Computerized Clinical Decision Support System
TAŞ Z., METAN G., TELLİ DİZMAN G., Yavuz E., DİZDAR Ö., BÜYÜKAŞIK Y., et al.
ANTIBIOTICS-BASEL
, cilt.13, sa.9, 2024 (SCI-Expanded, Scopus)
2024
202418. Predictors of early mortality after hemodialysis in patients with cancer and acute kidney injury
Gurbuz S. C., Kavgaci G., Sahin T. K., Kertmen N., Arici M., Dizdar O.
ANNALS OF ONCOLOGY
, 2024 (SCI-Expanded, Scopus)
2024
202419. Impact of opioid analgesics on survival in cancer patients receiving immune checkpoint inhibitors
KAVGACI G., GÜVEN D. C., KAYGUSUZ Y., KARACA E., DİZDAR Ö., Kilickap S., et al.
SUPPORTIVE CARE IN CANCER
, cilt.32, sa.7, 2024 (SCI-Expanded, Scopus)
2024
202420. Acute heart failure following pazopanib treatment: a literature review featuring two case reports
KERTMEN N., KAVGACI G., YILDIRIM H. Ç., DİZDAR Ö.
Anti-Cancer Drugs
, cilt.35, sa.3, ss.302-304, 2024 (SCI-Expanded, Scopus)
2024
202421. The prognostic and predictive role of class III β-Tubulin and hENT1 expression in patients with advanced pancreatic ductal adenocarcinoma
Sahin T., IŞIK A., Guven D., Ceylan F., BABAOĞLU B., AKYOL A., et al.
Pancreatology
, cilt.24, sa.2, ss.279-288, 2024 (SCI-Expanded, Scopus)
2024
202422. Sirolimus experience in adult patients with vascular malformations
AKYILDIZ A., Ismayilov R., GÜVEN D. C., YILDIRIM H. Ç., Tatar O. D., KUŞ F., et al.
Vascular
, 2024 (SCI-Expanded, Scopus)
2024
202423. Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy
Sahin T. K., ÖZBAY Y., ALTUNBULAK A. Y., ALTUNBULAK H. İ., ONUR M. R., Ceylan F., et al.
International Journal of Clinical Oncology
, 2024 (SCI-Expanded, Scopus)
2024
202424. Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS)
BİLGİN E., Demirci Yıldırım T., Özdemir Ulusoy B., Öğüt T. S., Karabacak M., Sadioğlu Çağdaş Ö., et al.
Internal and Emergency Medicine
, 2024 (SCI-Expanded, Scopus)
2023
202325. A meta-analysis of the association between adjuvant chemoradiotherapy and disease-free survival in gastric cancer according to the histology
YILDIRIM H. Ç., GÜVEN D. C., AKYILDIZ A., YALÇIN Ş., DİZDAR Ö.
Irish Journal of Medical Science
, cilt.192, sa.6, ss.2631-2634, 2023 (SCI-Expanded, Scopus)
2023
202326. The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey
AKYILDIZ A., GÜVEN D. C., Ozluk A. A., Ismayilov R., Mutlu E., Unal O. U., et al.
Medicine
, cilt.102, sa.45, 2023 (SCI-Expanded, Scopus)
2023
202327. A chance in hopeless cancer: 5-year complete remission after oxaliplatin-based therapy in a patient with BRCA2 mutant metastatic pancreatic cancer
YILDIRIM H. Ç., Ismayilov R., AKYILDIZ A., GÜVEN D. C., Abdurrahimli N., DİZDAR Ö., et al.
Anti-cancer drugs
, cilt.34, sa.10, ss.1190-1192, 2023 (SCI-Expanded, Scopus)
2023
202328. Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia
AKTAŞ B. Y., ATA E. B., ÇEŞMECİ E., ÇAKIR İ. Y., Coşkunpınar M., TAHILLIOĞLU Y., et al.
Current Oncology
, cilt.30, sa.11, ss.9689-9700, 2023 (SCI-Expanded, Scopus)
2023
202329. Mean Platelet Volume to Lymphocyte Ratio: A New Biomarker Predicting Response in Patients with Solid Tumors Treated with Nivolumab
YILDIRIM H. Ç., KUŞ F., GÜVEN D. C., Karaca E., KAYGUSUZ Y., DİZDAR Ö., et al.
Journal of Immunotherapy and Precision Oncology
, cilt.6, sa.4, ss.170-176, 2023 (Scopus)
2023
202330. Molecularly imprinted electrochemical sensor for the selective and sensitive determination of octreotide in cancer patient plasma sample
Ozkan E., Ozcelikay G., Gök Topak E. D., NEMUTLU E., ÖZKAN S. A., DİZDAR Ö., et al.
Talanta
, cilt.263, 2023 (SCI-Expanded, Scopus)
2023
202331. Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry
Duran E., Ozturk Z. O., BİLGİN E., BÜYÜKAŞIK Y., DİZDAR Ö., Yardimci G. K., et al.
Rheumatology and Therapy
, cilt.10, sa.4, ss.969-981, 2023 (SCI-Expanded, Scopus)
2023
202332. Advances in the Early Detection of Hepatobiliary Cancers
YILDIRIM H. Ç., KAVGACI G., Chalabiyev E., DİZDAR Ö.
Cancers
, cilt.15, sa.15, 2023 (SCI-Expanded, Scopus)
2023
202333. The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitors
GÜVEN D. C., ÖZBEK D. A., ŞAHİN T. K., KAVGACI G., Aksun M. S., ERUL E., et al.
Anti-Cancer Drugs
, cilt.34, sa.6, ss.783-790, 2023 (SCI-Expanded, Scopus)
2023
202334. SMART syndrome: a case report
Bozkurt S., Toprak B., YILDIRIM H. Ç., PARLAK SAĞOL Ş., GÜVEN D. C., KERTMEN N., et al.
ACTA NEUROLOGICA BELGICA
, cilt.123, sa.3, ss.1137-1140, 2023 (SCI-Expanded, Scopus)
2023
202335. Retrospective Evaluation of the Efficacy of Gemcitabine-Based Therapies After FOLFIRINOX Failure in Advanced Pancreatic Cancer, Multi-Center Real-Life Data
Sütcüoğlu O., Doğan A., Yilmaz F., Şahin A. B., ŞAHİN T. K., Esen S. A., et al.
Pancreas
, cilt.52, sa.4, 2023 (SCI-Expanded, Scopus)
2023
202336. Prognostic and predictive value of tumoral DNA damage repair protein expression in patients with resected pancreatic cancer
Ceylan F., Guven D. C., Taban H., Aktepe O., ŞAHİN T. K., Kilickap S., et al.
Clinics and Research in Hepatology and Gastroenterology
, cilt.47, sa.3, 2023 (SCI-Expanded, Scopus)
2023
202337. Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy
GÜVEN D. C., Incesu F. G. G., YILDIRIM H. Ç., Erul E., Chalabiyev E., AKTAŞ B. Y., et al.
INTERNATIONAL JOURNAL OF CANCER
, cilt.152, ss.679-685, 2023 (SCI-Expanded, Scopus)
2023
202338. Smoker Relatives of Inpatients: A Reasonable but Heterogeneous Target Population for Smoking Cessation Program
AKTAŞ B. Y., HÜSEYİN B., YÜCE D., DİZDAR Ö., ERMAN M., HAYRAN M., et al.
Archives of Basic and Clinical Research
, cilt.5, sa.1, ss.178-184, 2023 (TRDizin)
2023
202339. Prognostic Value of Androgen Receptor Expression in Premenopausal Women with Estrogen Receptor-Positive Breast Cancer
YILDIRIM H. Ç., ÜNER M., Yildiran Özmen T., Chalabiyev E., GÜVEN D. C., KUŞ F., et al.
Journal of Oncological Science
, cilt.9, sa.1, ss.33-37, 2023 (Scopus, TRDizin)
2023
202340. Emerging treatment strategies in hepatobiliary cancer
GÜVEN D. C., YILDIRIM H. Ç., Chalabiyev E., KUŞ F., YILMAZ F., YAŞAR S., et al.
Expert Review of Anticancer Therapy
, cilt.23, sa.3, ss.243-256, 2023 (SCI-Expanded, Scopus)
2023
202341. Optimal adjuvant treatment strategies for TNBC patients with residual disease after neoadjuvant treatment
Guven D. C., YILDIRIM H. Ç., KUŞ F., Erul E., KERTMEN N., DİZDAR Ö., et al.
Expert Review of Anticancer Therapy
, cilt.23, sa.10, ss.1049-1059, 2023 (SCI-Expanded, Scopus)
2022
202242. Lesson learned from the pandemic: Isolation and hygiene measures for COVID-19 could reduce the nosocomial infection rates in oncology wards
GÜVEN D. C., EROĞLU İ., Ismayilov R., ULUSOYDAN E., AKTEPE O. H., TELLİ DİZMAN G., et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
, cilt.28, sa.8, ss.1807-1811, 2022 (SCI-Expanded, Scopus)
2022
202243. Prognosis of Liposarcoma Patients in Modern ERA: Single-Center Experience
DEMİR M., Guven D., AKTAŞ B. Y., GÜNER G., AKTEPE O. H., TABAN H., et al.
SOUTH ASIAN JOURNAL OF CANCER
, cilt.11, ss.287-292, 2022 (ESCI, Scopus)
2022
202244. Comparison of Clinical and Pathological Factors Affecting Early and Late Recurrences in Patients with Operable Breast Cancer
YEKEDÜZ E., DİZDAR Ö., KERTMEN N., AKSOY S.
JOURNAL OF CLINICAL MEDICINE
, cilt.11, sa.9, 2022 (SCI-Expanded, Scopus)
2022
202245. HER2-low breast cancer could be associated with an increased risk of brain metastasis
GÜVEN D. C., KAYA M. B., Fedai B., ÖZDEN M., YILDIRIM H. Ç., KÖSEMEHMETOĞLU K., et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
, cilt.27, sa.2, ss.332-339, 2022 (SCI-Expanded, Scopus)
2022
202246. Adjuvant treatment with paclitaxel plus trastuzumab for node-negative breast cancer: real-life experience
Diker O., AKTAŞ B. Y., Ak R., KÖYLÜ B., BAŞ O., TABAN H., et al.
FUTURE ONCOLOGY
, cilt.18, ss.323-331, 2022 (SCI-Expanded, Scopus)
2022
202247. Liquid biopsy: Novel perspectives on the importance and spectrum of PIK3CA, PTEN and RET mutations in solid tumors
Sahin I., Saat H., AKSOY S., DİZDAR Ö., Erdem H. B., Bahsi T.
MOLECULAR AND CLINICAL ONCOLOGY
, cilt.16, sa.1, 2022 (ESCI, Scopus)
2022
202248. The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life study
GÜVEN D. C., YILDIRIM H. Ç., ERUL E., ŞAHİN T. K., ÇAKIR İ. Y., AKTEPE O. H., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.52, sa.5, ss.1551-1558, 2022 (SCI-Expanded, Scopus, TRDizin)
2022
202249. Prognostic Factors Associated with Locally Advanced Gastric Cancer in Patients Treated with Adjuvant Chemotherapy
YILDIRIM H. Ç., Güven D. C., Chalabiyev E., Taban H., YILMAZ F., YAŞAR S., et al.
Journal of Oncological Science
, cilt.8, sa.3, ss.143-147, 2022 (Scopus, TRDizin)
2022
202250. Adjuvant Capecitabine In Triple Negative Breast Cancer: The Earlier, The Better? Comment
Guven D. C., Taban H., Dizdar O.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
, cilt.28, sa.1, ss.203-204, 2022 (SCI-Expanded, Scopus)
2022
202251. Differences between Hyperprogressive Disease and Progressive Disease in Patients Receiving Immunotherapy
YILDIRIM H. Ç., GÜVEN D. C., AKTEPE O. H., TABAN H., YILMAZ F., YAŞAR S., et al.
EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY
, cilt.6, sa.1, ss.59-63, 2022 (ESCI, TRDizin)
2021
202152. The association between albumin-globulin ratio (AGR) and survival in patients treated with immune checkpoint inhibitors
Guven D. C., Aktepe O. H., Aksun M. S., Sahin T. K., Kavgaci G., Ucgul E., et al.
ANNALS OF ONCOLOGY
, cilt.32, 2021 (SCI-Expanded, Scopus)
2021
202153. Correlation Between THSD7A Expression and Tumor Characteristics of Azoxymethane-Induced Colon Cancer Model in Rats
AKTEPE O. H., ŞAHİN T. K., GÜNER G., GÜVEN D. C., YETER H. H., KURTULAN O., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.32, sa.12, ss.1049-1056, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
202154. A systematic review and meta-analysis of the association between circulating tumor DNA (ctDNA) and prognosis in pancreatic cancer
GÜVEN D. C., ŞAHİN T. K., YILDIRIM H. Ç., AKTEPE O. H., DİZDAR Ö., YALÇIN Ş.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
, cilt.168, 2021 (SCI-Expanded, Scopus)
2021
202155. The Predictive Value of Red Blood Cell Distribution Width for Survival Outcomes of Metastatic Renal Cell Carcinoma Patients Treated with Targeted Therapy
AKTEPE O. H., GÜVEN D. C., ŞAHİN T. K., YILDIRIM H. Ç., ÇELİKTEN B., Yeter H. H., et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
, cilt.73, sa.10, ss.1957-1963, 2021 (SCI-Expanded, Scopus)
2021
202156. Newly diagnosed cancer and the COVID-19 pandemic: tumour stage migration and higher early mortality
GÜVEN D. C., ŞAHİN T. K., YILDIRIM H. Ç., ÇEŞMECİ E., Incesu F. G. G., TAHILLIOĞLU Y., et al.
BMJ SUPPORTIVE & PALLIATIVE CARE
, 2021 (SCI-Expanded, Scopus)
2021
202157. Sarcopenia and anthracycline cardiotoxicity in patients with cancer
BAŞ O., ERDEMİR A. G., ONUR M. R., ÖZER N., ŞENER Y. Z., AKSU S., et al.
BMJ SUPPORTIVE & PALLIATIVE CARE
, 2021 (SCI-Expanded, Scopus)
2021
202158. Lower prognostic nutritional index is associated with poorer survival in patients receiving immune-checkpoint inhibitors
GÜVEN D. C., AKTEPE O. H., TABAN H., AKTAŞ B. Y., GÜNER G., YILDIRIM H. H., et al.
BIOMARKERS IN MEDICINE
, cilt.15, sa.13, ss.1123-1130, 2021 (SCI-Expanded, Scopus)
2021
202159. Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy
GÜVEN D. C., AKSUN M. S., ŞAHİN T. K., AKTEPE O. H., YILDIRIM H. Ç., TABAN H., et al.
SUPPORTIVE CARE IN CANCER
, cilt.29, sa.9, ss.5417-5423, 2021 (SCI-Expanded, Scopus)
2021
202160. PILE: a candidate prognostic score in cancer patients treated with immunotherapy
Guven D. C., Yildirim H. C., Bilgin E., Aktepe O. H., Taban H., Sahin T. K., et al.
CLINICAL & TRANSLATIONAL ONCOLOGY
, cilt.23, sa.8, ss.1630-1636, 2021 (SCI-Expanded, Scopus)
2021
202161. Chemoimmunotherapy for the salvage treatment of Ewing sarcoma: A case report
GÜVEN D. C., KILIÇKAP S., YILDIRIM H. Ç., Ceylan F., BAŞ O., DİZDAR Ö.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
, cilt.27, sa.5, ss.1281-1283, 2021 (SCI-Expanded, Scopus)
2021
202162. Clinical features and outcomes of COVID-19 in patients with solid tumors: Turkish National Registry Data
Ozdemir N., DİZDAR Ö., YAZICI O., AKSOY S., Dede D. S., Budakoglu B., et al.
INTERNATIONAL JOURNAL OF CANCER
, cilt.148, sa.10, ss.2407-2415, 2021 (SCI-Expanded, Scopus)
2021
202163. THE INCIDENCE AND RISK FACTORS FOR ACUTE KIDNEY INJURY IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A REAL-LIFE STUDY
GÜVEN D. C., ÖZBEK D. A., ŞAHİN T. K., AKSUN M. S., KAVGACI G., Cebrayilov C., et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION
, cilt.36, 2021 (SCI-Expanded, Scopus)
2021
202164. Evaluation of emergency departments visits in patients treated with immune checkpoint inhibitors
GÜVEN D. C., ŞAHİN T. K., AKSUN M. S., TABAN H., AKTEPE O. H., METİN AKSU N., et al.
SUPPORTIVE CARE IN CANCER
, cilt.29, sa.4, ss.2029-2035, 2021 (SCI-Expanded, Scopus)
2021
202165. Comments on "Survival impact of adjuvant chemotherapy in patients with stageIIAcolon cancer: Analysis of the National Cancer Database"
DİZDAR Ö.
INTERNATIONAL JOURNAL OF CANCER
, cilt.148, sa.4, ss.1027, 2021 (SCI-Expanded, Scopus)
2021
202166. Turkish society of medical oncology covid-19 pandemic advisory board updated recommendations for medical oncologists: Included vaccination
Sümbül A. T., YALÇIN S. S., ÖZET A., ÜNAL S., DİZDAR Ö., AKBULUT H., et al.
Journal of Oncological Science
, cilt.7, sa.1, ss.1-6, 2021 (Scopus, TRDizin)
2021
202167. Prognostic and predictive value of tumor-infiltrating lymphocytes in combination with systemic inflammatory markers in colon cancer
Efil S. C., Guner G., Guven D. C., Celikten B., Celebiyev E., Taban H., et al.
ANNALS OF ONCOLOGY
, cilt.32, 2021 (SCI-Expanded, Scopus)
2021
202168. What to expect from NCCN BRCA testing criteria: A retrospective cohort analysis
Aktas B. Y., Degirmenciler R. F., Durmaz C. D., Taban H., Guven D. C., Guner G., et al.
ANNALS OF ONCOLOGY
, cilt.32, 2021 (SCI-Expanded, Scopus)
2020
202069. Cancer incidence in Behcet's disease
GÜVEN D. C., BÖLEK E. Ç., ALTINTOP S. E., ÇELİKTEN B., AKTAŞ B. Y., KİRAZ S., et al.
IRISH JOURNAL OF MEDICAL SCIENCE
, cilt.189, sa.4, ss.1209-1214, 2020 (SCI-Expanded, Scopus)
2020
202070. Predictive biomarkers for immunotherapy efficacy in non-small-cell lung cancer: current status and future perspectives
C Guven D., ŞAHİN T. K., DİZDAR Ö., KILIÇKAP S.
BIOMARKERS IN MEDICINE
, cilt.14, ss.1383-1392, 2020 (SCI-Expanded, Scopus)
2020
202071. All Positives May Not Be the Same in Pancreatic Cancer Lessons Learned From the Past
Ceylan F., GÜVEN D. C., ŞAHİN T. K., ÖZBEK D. A., DİZDAR Ö.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
, cilt.43, sa.9, ss.676, 2020 (SCI-Expanded, Scopus)
2020
202072. Cancer incidence in Behcet's Disease.
Guven D. C., Bolek E. C., Altintop S. E., Celikten B., Aktas B. Y., Kiraz S., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.38, sa.15, 2020 (SCI-Expanded, Scopus)
2020
202073. Complete responses to two different anti-PD1 agents in a metastatic melanoma patient
KILIÇKAP S., GÜVEN D. C., AKTEPE O. H., AKTAŞ B. Y., DİZDAR Ö.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
, cilt.26, sa.2, ss.496-499, 2020 (SCI-Expanded, Scopus)
2020
202074. The Effects of Different Treatment Modalities on the Disease Course and Survival in Patients with Hepatocellular Cancer
Lacin S., Karakas Y., DİZDAR Ö., KILIÇKAP S., Hassan M. M., Xiao L., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.30, sa.2, ss.94-102, 2020 (SCI-Expanded, Scopus, TRDizin)
2020
202075. Development of de novo psoriasis during nivolumab therapy in a patient with small cell lung cancer
GÜVEN D. C., KILIÇKAP S., GÜNER G., TABAN H., DİZDAR Ö.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
, cilt.26, sa.1, ss.256-258, 2020 (SCI-Expanded, Scopus)
2019
201976. Classifying sarcopenia: using median value or cut-off values?
BAŞ O., DİZDAR Ö.
BREAST CANCER RESEARCH AND TREATMENT
, cilt.176, sa.2, ss.479, 2019 (SCI-Expanded, Scopus)
2019
201977. Exploiting DNA repair defects in breast cancer: from chemotherapy to immunotherapy
AKTAŞ B. Y., Guner G., Guven D. C., Arslan C., DİZDAR Ö.
EXPERT REVIEW OF ANTICANCER THERAPY
, cilt.19, sa.7, ss.589-601, 2019 (SCI-Expanded, Scopus)
2019
201978. Cancer incidence in familial Mediterranean fever patients: a retrospective analysis from central Anatolia
BİLGİN E., DİZDAR Ö., Guven D. C., Ceylan S., AYBI Ö., FIRLATAN B., et al.
Rheumatology International
, cilt.39, sa.6, ss.1045-1051, 2019 (SCI-Expanded, Scopus)
2019
201979. Analysis of Fusobacterium nucleatum and Streptococcus gallolyticus in saliva of colorectal cancer patients
Guven D. C., DİZDAR Ö., ALP A., AKDOĞAN KITTANA F. N., KARAKOÇ D., HAMALOĞLU E., et al.
BIOMARKERS IN MEDICINE
, cilt.13, sa.9, ss.725-735, 2019 (SCI-Expanded, Scopus)
2019
201980. Short-time use of crizotinib as neoadjuvant in ALK-positive non-small cell lung carcinoma can be a chance for resectability
KILIÇKAP S., Onder S., DİZDAR Ö., ERMAN M., ÜNER A.
CANCER CHEMOTHERAPY AND PHARMACOLOGY
, cilt.83, sa.6, ss.1195-1196, 2019 (SCI-Expanded, Scopus)
2019
201981. The frequency and predictors of persistent amenorrhea in premenopausal women with colorectal cancer who received adjuvant chemotherapy
ŞAHİN T., DİZDAR Ö., Ozdemir N., Zengin N., Ates O., Oksuzoglu B., et al.
ANTI-CANCER DRUGS
, cilt.30, sa.3, ss.289-294, 2019 (SCI-Expanded, Scopus)
2019
201982. Noninferiority for Short-HER or short-chemotherapy?
Aktas B. Y., Guven D. C., Dizdar O.
ANNALS OF ONCOLOGY
, cilt.30, sa.1, ss.147, 2019 (SCI-Expanded, Scopus)
2019
201983. Evaluation of cancer risk in patients with periodontal diseases
Guven D. C., DİZDAR Ö., AKMAN A. C., Berker E., Yekeduz E., Ceylan F., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.49, sa.3, ss.826-831, 2019 (SCI-Expanded, Scopus, TRDizin)
2018
201884. Glucocorticoids in breast cancer treatment: real benefit or selection bias?
Guner G., DİZDAR Ö.
BREAST CANCER RESEARCH AND TREATMENT
, cilt.172, sa.1, ss.243, 2018 (SCI-Expanded, Scopus)
2018
201885. When side effect becomes the effect: Efficacy of capecitabine in refractory psoriasis
Karakas Y., Vural S., DIKER O., DİZDAR Ö.
DERMATOLOGIC THERAPY
, cilt.31, sa.6, 2018 (SCI-Expanded, Scopus)
2018
201886. EFFECTS OF CANCER TYPES ON LOCAL AND OUT-OF-CITY ADMISSIONS FOR MEDICAL CARE
HAYRAN K. M., Yuce D., Kilickap S., Dizdar O., Huseyin B., Erman M., et al.
VALUE IN HEALTH
, cilt.21, 2018 (SCI-Expanded, SSCI, Scopus)
2018
201887. TRANSCULTURAL ADAPTATION OF EORTC-QLQ-CR29 SCALE INTO TURKISH, AND ASSESSMENT OF VALIDITY AND RELIABILITY IN TURKISH PATIENTS WITH COLORECTAL CANCER
HAYRAN K. M., Yuce D., Kilickap S., Huseyin B., Erman M., Dizdar O., et al.
VALUE IN HEALTH
, cilt.21, 2018 (SCI-Expanded, SSCI, Scopus)
2018
201888. The Effect of Total Size of Lesions in Multifocal/Multicentric Breast Cancer on Survival
KARAKAS Y., DİZDAR Ö., AKSOY S., Hayran M., Altundag K.
CLINICAL BREAST CANCER
, cilt.18, sa.4, ss.320-327, 2018 (SCI-Expanded, Scopus)
2018
201889. Familial Mediterranean fever: new insights into cancer immunoprevention? Comment on the article by Brenner et al
BİLGİN E., Erden A., DİZDAR Ö.
ARTHRITIS & RHEUMATOLOGY
, cilt.70, sa.7, ss.1167, 2018 (SCI-Expanded, Scopus)
2018
201890. Real world survival data of a rare malignancy: Anal cancer results in HIV negative patients from Turkey
ESİN E., YILDIZ F., Lacin S., KARAKAS Y., GÜLTEKİN M., DİZDAR Ö., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.29, sa.4, ss.411-418, 2018 (SCI-Expanded, Scopus, TRDizin)
2018
201891. Factors associated with quitting action following smoking cessation counseling.
Hayran K. M., Yuce D., Erman M., Dizdar O., Kilickap S., HUSEYIN B.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.36, sa.15, 2018 (SCI-Expanded, Scopus)
2018
201892. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcoma
AKIN S., DİZDAR Ö., KARAKAS Y., Turker A., Kars A.
CURRENT PROBLEMS IN CANCER
, cilt.42, sa.3, ss.344-349, 2018 (SCI-Expanded, Scopus)
2018
201893. Fusobacterium and colorectal carcinogenesis
Guven D. C., DİZDAR Ö.
CARCINOGENESIS
, cilt.39, sa.1, ss.84, 2018 (SCI-Expanded, Scopus)
2017
201794. Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial Neoplasms
AKIN S., DİZDAR Ö., Hayran M.
ANNALS OF SURGICAL ONCOLOGY
, cilt.24, 2017 (SCI-Expanded, Scopus)
2017
201795. Tumor Sidedness and Prognosis in Colorectal Cancer: Is Microbiome the Missing Link?
KARAKAS Y., DİZDAR Ö.
JAMA ONCOLOGY
, cilt.3, sa.7, ss.1000, 2017 (SCI-Expanded, Scopus)
2017
201796. Evaluation of complementary and alternative medicine trials registered in clinicaltrials.gov database
DİZDAR Ö., BİLGİN E., AKIN S., KILIÇKAP S., HAYRAN M.
JOURNAL OF BUON
, cilt.22, sa.2, ss.530-534, 2017 (SCI-Expanded, Scopus)
2017
201797. Prognostic factors and treatment of patients with advanced synovial sarcoma: A single-center experience
Ates O., Aksoy S., Yeter H. H., Sunar V., Kertmen N., Dizdar O., et al.
INDIAN JOURNAL OF CANCER
, cilt.54, sa.1, ss.321-325, 2017 (SCI-Expanded, Scopus)
2017
201798. Increased cancer risk in patients with periodontitis
DİZDAR Ö., HAYRAN M., Guven D. C., YILMAZ T. B., TAHERI S., AKMAN A. C., et al.
CURRENT MEDICAL RESEARCH AND OPINION
, cilt.33, sa.12, ss.2195-2200, 2017 (SCI-Expanded, Scopus)
2016
201699. Vaccination perception and attitudes among patients with cancer receiving chemotherapy
AKIN Ş., DİZDAR Ö., Karakas Y., ÖZIŞIK L., Tanriover M. D., Kamisli S., et al.
ANNALS OF ONCOLOGY
, cilt.27, 2016 (SCI-Expanded, Scopus)
2016
2016100. Response rates of taxane rechallenge in metastatic breast cancer patients previously treated with adjuvant taxanes
Kucukoztas N., OĞUZ A., Rahatli S., Altundag O., Altundag K.
JOURNAL OF BUON
, cilt.21, sa.5, ss.1076-1081, 2016 (SCI-Expanded, Scopus)
2016
2016101. Interpretation of survival data: which graphical analysis is appropriate?
Dizdar O., AKIN S., HAYRAN M.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
, cilt.8, sa.4, ss.312, 2016 (SCI-Expanded, Scopus)
2016
2016102. Analysis of the Adjuvant Hormone Therapy Randomized Trial
Karakas Y., AKIN S., DİZDAR Ö., AKSOY S.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.34, sa.17, ss.2070-2071, 2016 (SCI-Expanded, Scopus)
2016
2016103. Vaccination Attitudes Among Patients with Cancer Receiving Chemotherapy
AKIN S., DİZDAR Ö., ÖZIŞIK L., TANRIOVER M., KAMISLI S., ERMAN M., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.26, sa.3, ss.167-172, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
2016104. Cytoreductive Surgery for Intestinal Cancer Patients Metastatic to Ovaries Presenting as Primary Ovarian Cancer
Arik Z., Oz M., DİZDAR Ö., YILDIRIM M. E., OZGU E., TERZIOGLU S. G., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.26, sa.2, ss.110-115, 2016 (SCI-Expanded, Scopus, TRDizin)
2015
2015105. Advances in PARP inhibitors for the treatment of breast cancer
DİZDAR Ö., Arslan C., ALTUNDAG K.
EXPERT OPINION ON PHARMACOTHERAPY
, cilt.16, sa.18, ss.2751-2758, 2015 (SCI-Expanded, Scopus)
2015
2015106. Is Dexamethasone a Better Partner for Abiraterone Than Prednisolone?
Dizdar O.
ONCOLOGIST
, cilt.20, sa.5, 2015 (SCI-Expanded, Scopus)
2015
2015107. The effect of renin-angiotensin-system inhibition on survival and recurrence of N3+breast cancer patients
BABACAN T., Balakan O., Kuzan T. Y., Sarici F., Koca E., KERTMEN N., et al.
JOURNAL OF BUON
, cilt.20, sa.1, ss.50-56, 2015 (SCI-Expanded, Scopus)
2014
2014108. Chemotherapy and biological treatment options in breast cancer patients with brain metastasis: an update
Arslan C., Dizdar O., ALTUNDAG K.
EXPERT OPINION ON PHARMACOTHERAPY
, cilt.15, sa.12, ss.1643-1658, 2014 (SCI-Expanded, Scopus)
2014
2014109. Good Outcomes of Patients with Stage IB Endometrial Cancer with Surgery Alone
RAHATLI S., DİZDAR Ö., KÜÇÜKÖZTAŞ N., OĞUZ A., YALÇIN S., ÖZEN Ö., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
, cilt.15, sa.9, ss.3891-3893, 2014 (SCI-Expanded, Scopus)
2014
2014110. Tertiary Cancer Center Experience: Pregnancy-Associated Breast Cancer
Kuzas T. Y., Koca E., BABACAN T., Turkbeyler I. H., Sarici F., Altundag K.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.24, sa.4, ss.284-285, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
2014111. Burnout syndrome during residency in internal medicine and pediatrics in a country without working time directive
YAZGAN AKSOY D., DURUSU TANRIÖVER M., ÜNAL S., DİZDAR Ö., KALYONCU U., KARAKAYA KARABULUT J., et al.
International Journal of Health Care Quality Assurance
, 2014 (Scopus)
2013
2013112. Low ERCC1 expression is associated with prolonged survival in patients with bladder cancer receiving platinum-based neoadjuvant chemotherapy
OZCAN M. F., Dizdar O., DINCER N., BALCI S., Guler G., GOK B., et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
, cilt.31, sa.8, ss.1709-1715, 2013 (SCI-Expanded, Scopus)
2013
2013113. Outcomes of locally advanced breast cancer patients with >= 10 positive axillary lymph nodes
KOCA E., KUZAN T. Y., Dizdar O., Babacan T., SAHIN I., ARARAT E., et al.
MEDICAL ONCOLOGY
, cilt.30, sa.3, 2013 (SCI-Expanded, Scopus)
2013
2013114. Breast cancer in octogenarian women: clinical characteristics and outcome
Kuzan T. Y., Koca E., Dizdar O., Arslan C., Eren T., Yalcin S., et al.
JOURNAL OF BUON
, cilt.18, sa.2, ss.328-334, 2013 (SCI-Expanded, Scopus)
2013
2013115. Association of breast cancer subtypes and body mass index
Petekkaya I., ŞAHİN U., Gezgen G., Solak M., YÜCE D., DİZDAR Ö., et al.
TUMORI J
, cilt.99, sa.2, ss.129-133, 2013 (SCI-Expanded, Scopus)
2013
2013116. Safety of Tamoxifen During Pregnancy: 3 Case Reports and Review of the Literature
Koca E., Kuzan T. Y., BABACAN T., Turkbeyler I. H., Sarici F., Altundag K.
BREAST CARE
, cilt.8, sa.6, ss.453-454, 2013 (SCI-Expanded, Scopus)
2013
2013117. Frequency of thyroid disease among breast cancer patients: a descriptive study of breast cancer patients
Vural O., Dizdar O., Petekkaya I., Alnak A., Babacan T., Altundag K.
JOURNAL OF BUON
, cilt.18, sa.1, ss.294-295, 2013 (SCI-Expanded, Scopus)
2013
2013118. Impact of Treatment Strategies on Local Control and Survival in Uterine Carcinosarcomas in Turkey
Kucukoztas N., Dizdar O., Rahatli S., Dursun P., Yalcin S., Altundag O., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
, cilt.14, sa.5, ss.2959-2962, 2013 (SCI-Expanded, Scopus)
2012
2012119. Joint problems in breast cancer patients receiving adjuvant aromatase inhibitor
Kuria I. M., Petekkaya I., Hasanov E., Babacan T., Dizdar O., Altundag K.
JOURNAL OF BUON
, cilt.17, sa.4, ss.798-799, 2012 (SCI-Expanded, Scopus)
2012
2012120. Neuromyotonia forerunning the diagnosis of an eventual thymoma
Ozcakar L., Ozcan H. N., Dizdar O., Karaoglanoglu N., Tan E.
EUROPEAN JOURNAL OF NEUROLOGY
, cilt.19, sa.9, 2012 (SCI-Expanded, Scopus)
2012
2012121. Frequency of HCV infection in renal cell carcinoma patients
Budakoglu B., Aksoy S., ARSLAN Ç., Uyeturk U., Babacan N. A., Ozcan M. F., et al.
MEDICAL ONCOLOGY
, cilt.29, sa.3, ss.1892-1895, 2012 (SCI-Expanded, Scopus)
2012
2012122. Phase II Study of Loading-Dose Ibandronate Treatment in Patients with Breast Cancer and Bone Metastases Suffering from Moderate to Severe Pain
Altundag K., DİZDAR Ö., ÖZSARAN Z., ÖZKÖK S., Saip P., Eralp Y., et al.
ONKOLOGIE
, cilt.35, sa.5, ss.254-258, 2012 (SCI-Expanded, Scopus)
2011
2011123. Breast cancer subtypes and outcomes of central nervous system metastases
Arslan U. Y., Oksuzoglu B., AKSOY S., Harputluoglu H., Turker I., Ozisik Y., et al.
BREAST
, cilt.20, sa.6, ss.562-567, 2011 (SCI-Expanded, Scopus)
2011
2011124. Demographic and clinico-pathological characteristics in patients with triple-negative and non-triple-negative breast cancer
BULUT N., AKSOY S., DİZDAR Ö., Dede D. S., Arslan C., DOĞAN E., et al.
MEDICAL ONCOLOGY
, cilt.28, 2011 (SCI-Expanded, Scopus)
2011
2011125. Multimodality Treatment in the Management of Anorectal Melanoma: A Case Report and Review of the Literature
Tapan U., DİZDAR Ö., Bulut N., ÇELİK İ.
EURASIAN JOURNAL OF MEDICINE
, cilt.43, sa.3, ss.189-191, 2011 (ESCI, TRDizin)
2011
2011126. Increased mean corpuscular volume of erythrocytes during capecitabine treatment: a simple surrogate marker for clinical response
ARSLAN Ç., AKSOY S., DİZDAR Ö., KURT M., Guler N., Ozisik Y., et al.
TUMORI
, cilt.97, sa.6, ss.711-716, 2011 (SCI-Expanded, Scopus)
2011
2011127. Vitamin D intake may be effective in the management of triple-negative breast cancer
Harputluoglu H., Dizdar O., Karaahmet F., Altundag K.
JOURNAL OF BUON
, cilt.16, sa.3, ss.569, 2011 (SCI-Expanded, Scopus)
2011
2011128. Pure mucinous carcinoma of the breast: a single center experience
Dogan E., Aksoy S., Dizdar O., Arslan C., Dede D. S., Ozisik Y., et al.
JOURNAL OF BUON
, cilt.16, sa.3, ss.565-567, 2011 (SCI-Expanded, Scopus)
2011
2011129. Frequency of HCV infection in renal cell carcinoma patients
Budakoglu B., Aksoy S., Arslan C., Uyeturk U., Babacan N. A., Ozcan M. F., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.29, sa.15, 2011 (SCI-Expanded, Scopus)
2011
2011130. Nilotinib is Effective in Imatinib and Sunitinib Resistant GIST: A Case Report
DİZDAR Ö., YALÇIN Ş.
HEPATO-GASTROENTEROLOGY
, cilt.58, sa.107, ss.859-860, 2011 (SCI-Expanded, Scopus)
2011
2011131. Clinicopathologic features of patients with breast cancer under teatment of bisphosphonate at the time of diagnosis: Retrospective analysis
Dede D. S., Arslan C., Aksoy S., Dizdar O., Dogan E., Alkan A., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.29, sa.15, 2011 (SCI-Expanded, Scopus)
2011
2011132. Clinical and pathological characteristics of very young breast cancer patients (<= 25 years of age)
Ararat E., Sahin I., Arslan C., Aksoy S., Dizdar O., Ozisik Y., et al.
JOURNAL OF BUON
, cilt.16, sa.2, ss.372, 2011 (SCI-Expanded, Scopus)
2011
2011133. Percentage of family history of cancer in patients with breast cancer: Is it changing with ethnicity?
Dizdar O., Arslan C., Altundag K.
JOURNAL OF BUON
, cilt.16, sa.2, ss.373, 2011 (SCI-Expanded, Scopus)
2011
2011134. Zoledronic acid and atrial fibrillation in cancer patients
ARSLAN Ç., AKSOY S., DİZDAR Ö., Dede D. S., HARPUTLUOĞLU H., ALTUNDAĞ M. K.
SUPPORTIVE CARE IN CANCER
, cilt.19, sa.3, ss.425-430, 2011 (SCI-Expanded, Scopus)
2011
2011135. Ipsilateral Breast Cancer in a Patient with Poland's Syndrome
Yesilkaya Y., DİZDAR Ö., Altundag K.
AMERICAN SURGEON
, cilt.77, sa.2, ss.234-235, 2011 (SCI-Expanded, Scopus)
2011
2011136. Malignancies after rituximab treatment: just coincidence or more?
Aksoy S., Arslan C., Harputluoglu H., Dizdar O., Altundag K.
JOURNAL OF BUON
, cilt.16, sa.1, ss.112-115, 2011 (SCI-Expanded, Scopus)
2010
2010137. Blood ABO groups and risk of breast cancer
ŞENER DEDE D., AKSOY S., DİZDAR Ö., Cerci P., Gullu İ. H., Ozisik Y., et al.
MEDICAL ONCOLOGY
, cilt.27, sa.4, ss.1433, 2010 (SCI-Expanded, Scopus)
2010
2010138. Other malignancies in patients with breast cancer: a single institute experience
Dogan E., AKSOY S., DİZDAR Ö., ŞENER DEDE D., ARSLAN Ç., Ozisik Y., et al.
MEDICAL ONCOLOGY
, cilt.27, sa.4, ss.1434-1435, 2010 (SCI-Expanded, Scopus)
2010
2010139. Two Important Determinants May Play a Role in the Success of the FinHer Trial
Isik M., DİZDAR Ö., Altundag K.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.28, sa.20, 2010 (SCI-Expanded, Scopus)
2010
2010140. Renal safety and osteonecrosis of the jaw in cancer patients receiving intravenous bisphosphonates
AKSOY S., DİZDAR Ö., Altundag K.
MEDICAL ONCOLOGY
, cilt.27, sa.2, ss.568, 2010 (SCI-Expanded, Scopus)
2010
2010141. Phase II study of loading-dose ibandronate treatment in patients in breast cancer and bone metastases suffering from moderate to severe pain
Dizdar O., Altundag M. K., Ozkok S., Ozsaran Z., Saip P., Eralp Y., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.28, sa.15, 2010 (SCI-Expanded, Scopus)
2010
2010142. Increased mean corpuscular volume of erythrocytes with capecitabine treatment in metastatic breast cancer patients: A marker of clinical benefit?
Aksoy S., Arslan C., Kurt M., Dizdar O., Dede D. S., Dogan E., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.28, sa.15, 2010 (SCI-Expanded, Scopus)
2010
2010143. Docetaxel/doxorubicin/cyclophosphamide (TAC) chemotherapy for operable HER2-negative, node-positive breast cancer patients: Results from a single institution.
Surmell Z. G., Aksoy S., Dizdar O., Dede D. S., Dogan E., Arslan C., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.28, sa.15, 2010 (SCI-Expanded, Scopus)
2010
2010144. Systemic treatment in breast-cancer patients with brain metastasis
Arslan C., DİZDAR Ö., Altundag K.
EXPERT OPINION ON PHARMACOTHERAPY
, cilt.11, sa.7, ss.1089-1100, 2010 (SCI-Expanded, Scopus)
2010
2010145. Addition of nine weeks of trastuzumab to adjuvant chemotherapy in operable HER2-positive breast cancer patients: Retrospective analysis.
Ozen M., Aksoy S., Dizdar O., Dede D. S., Dogan E., Arslan C., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.28, sa.15, 2010 (SCI-Expanded, Scopus)
2010
2010146. Clinical and pathological characteristics of breast cancer patients with history of tonsillectomy
Isik M., AKSOY S., Dede D. S., DİZDAR Ö., Kara A., Gullu İ. H., et al.
BREAST
, cilt.19, sa.2, ss.152, 2010 (SCI-Expanded, Scopus)
2010
2010147. Skin metastasis of ovarian cancer: a rare entity
Arslan C., Dede D. S., Dizdar O., Altundag K.
JOURNAL OF BUON
, cilt.15, sa.2, ss.398-399, 2010 (SCI-Expanded, Scopus)
2010
2010148. Synchronous Ovarian Cancer in a Patient with Pleomorphic Lobular Breast Cancer: A Therapeutic Dilemma
Dizdar O., Arslan C., Altundag K.
CLINICAL ONCOLOGY
, cilt.22, sa.2, ss.153-154, 2010 (SCI-Expanded, Scopus)
2010
2010149. Clinical and pathological characteristics of breast cancer patients with history of cesarean delivery
Kalan I., Turgut D., AKSOY S., ŞENER DEDE D., DİZDAR Ö., Ozisik Y., et al.
BREAST
, cilt.19, sa.1, ss.67-68, 2010 (SCI-Expanded, Scopus)
2010
2010150. Current and emerging treatment options in triple-negative breast cancer
DİZDAR Ö., Altundag K.
ONCOLOGY REVIEWS
, cilt.4, sa.1, ss.5-13, 2010 (ESCI, Scopus)
2010
2010151. Estrogen receptor immunohistochemistry cutoff value: Standardization is needed
ARSLAN Ç., DİZDAR Ö., Altundag K.
HUMAN PATHOLOGY
, cilt.41, sa.1, ss.150, 2010 (SCI-Expanded, Scopus)
2009
2009152. Sonographic and Electrodiagnostic Evaluations in Patients With Aromatase Inhibitor-Related Arthralgia
DİZDAR Ö., Oezcakar L., Malas F. U., HARPUTLUOĞLU H., Bulut N., Aksoy S., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.27, sa.30, ss.4955-4960, 2009 (SCI-Expanded, Scopus)
2009
2009153. Chemotherapy in Older Women with Breast Cancer
DİZDAR Ö., ŞENER DEDE D., Altundag K.
NEW ENGLAND JOURNAL OF MEDICINE
, cilt.361, sa.10, ss.1023, 2009 (SCI-Expanded, Scopus)
2009
2009154. Pharmacotherapy of triple-negative breast cancer
ARSLAN Ç., DİZDAR Ö., Altundag K.
EXPERT OPINION ON PHARMACOTHERAPY
, cilt.10, sa.13, ss.2081-2093, 2009 (SCI-Expanded, Scopus)
2009
2009155. Pathological characteristics of very young (<= 30 years) breast cancer patients: a single-institution experience from Turkey
Aksoy S., Bulut N., Dizdar O., Tosur M., Meral A., Altundag K.
ANNALS OF ONCOLOGY
, cilt.20, sa.4, ss.790, 2009 (SCI-Expanded, Scopus)
2009
2009156. Reproductive and Hormonal Risk Factors for Postmenopausal Luminal, HER-2-overexpressing, and Triple-negative Breast Cancer
DİZDAR Ö., AKSOY S., Altundag K.
CANCER
, cilt.115, sa.8, ss.1802, 2009 (SCI-Expanded, Scopus)
2009
2009157. Emerging drugs in metastatic breast cancer
DİZDAR Ö., Altundag K.
EXPERT OPINION ON EMERGING DRUGS
, cilt.14, sa.1, ss.85-98, 2009 (SCI-Expanded, Scopus)
2009
2009158. Alterations of von Willebrand Factor and Ristocetin Cofactor Activity During Atrial Fibrillation
KALYONCU U., DİZDAR Ö., Duman A. E., KARADAĞ Ö., TUFAN A., Yucel O., et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
, cilt.15, sa.1, ss.103-108, 2009 (SCI-Expanded, Scopus)
2009
2009159. Is initially metastatic breast carcinoma different from recurrent metastatic breast carcinoma?
Dizdar O., Aksoy S., Altundag K.
ANNALS OF ONCOLOGY
, cilt.20, sa.1, ss.189, 2009 (SCI-Expanded, Scopus)
2008
2008160. Prognostic factors in long-term breast cancer survivors with brain metastases
Harputluoglu H., Kara A., DİZDAR Ö., Surmeli Z. G., Altundag K.
BREAST CANCER RESEARCH AND TREATMENT
, cilt.112, sa.1, ss.215, 2008 (SCI-Expanded, Scopus)
2008
2008161. Definition of postmenopausal status, age of the breast cancer patients and the outcome of aromatase inhibitors treatment
AKSOY S., DİZDAR Ö., Altundag K.
BREAST
, cilt.17, sa.5, ss.433-435, 2008 (SCI-Expanded, Scopus)
2008
2008162. Post-diagnosis statin use and breast recurrence sites in early stage breast cancer survivors
Harputluoglu H., DİZDAR Ö., Karaahmet F., Altundag K.
BREAST CANCER RESEARCH AND TREATMENT
, cilt.110, sa.3, ss.541, 2008 (SCI-Expanded, Scopus)
2008
2008163. Weekly paclitaxel in the adjuvant treatment of breast cancer
AKSOY S., DİZDAR Ö., Altundag K.
NEW ENGLAND JOURNAL OF MEDICINE
, cilt.359, sa.3, ss.310, 2008 (SCI-Expanded, Scopus)
2008
2008164. A case report: zoledronic acid-induced anterior uveitis
KILIÇKAP S., Ozdamar Y., ALTUNDAĞ M. K., DİZDAR Ö.
MEDICAL ONCOLOGY
, cilt.25, sa.2, ss.238-240, 2008 (SCI-Expanded, Scopus)
2008
2008165. Aromatase inhibitor-associated arthralgia: Prevalence, clinical and serum parameters among Turkish postmenopausal breast cancer patients
Harputluoglu H., Dizdar O., Malas F. U., Ozcakar L., Bulut N., Ozisik Y., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.26, sa.15, 2008 (SCI-Expanded, Scopus)
2008
2008166. Prognostic impact of bone turnover markers in multiple myeloma
Dizdar O., Barista I., Kalyoncu U., Karadag O., Celik I., Kars A., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.26, sa.15, 2008 (SCI-Expanded, Scopus)
2008
2008167. Clinicopathologic evaluation of non-Hodgkin lymphoma (NHL): A single centre experience
Kilickap S., Barista I., Turkmen E., Dizdar O., Aksoy S., Turker A., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.26, sa.15, 2008 (SCI-Expanded, Scopus)
2008
2008168. Vitamin D intake may be a predictor of response to aromatase inhibitors in postmenopausal women with hormone receptor positive breast cancer
DİZDAR Ö., Bulut N., Altundag K.
BREAST CANCER RESEARCH AND TREATMENT
, cilt.109, sa.2, ss.403, 2008 (SCI-Expanded, Scopus)
2008
2008169. Characteristics of breast cancer patients with central nervous system metastases: A single-center experience
Harputluoglu H., DİZDAR Ö., AKSOY S., KILIÇKAP S., Dede D. S., Ozisik Y., et al.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
, cilt.100, sa.5, ss.521-526, 2008 (SCI-Expanded, Scopus)
2008
2008170. Liver dysfunction after chemotherapy in lymphoma patients infected with hepatitis C
DİZDAR Ö., Tapan U., AKSOY S., Harputluoglu H., KILIÇKAP S., BARIŞTA İ.
EUROPEAN JOURNAL OF HAEMATOLOGY
, cilt.80, sa.5, ss.381-385, 2008 (SCI-Expanded, Scopus)
2008
2008171. Vitamin D supplementation and response to aromatase inhibitors in postmenopausal women with hormone-receptor positive breast cancer
DİZDAR Ö., Bulut N., Altundag K.
BREAST
, cilt.17, sa.2, ss.120, 2008 (SCI-Expanded, Scopus)
2008
2008172. Prognostic factors in breast cancer patients with brain metastases
Harputluoglu H., DİZDAR Ö., Altundag K.
JOURNAL OF NEURO-ONCOLOGY
, cilt.87, sa.2, ss.193, 2008 (SCI-Expanded, Scopus)
2008
2008173. Efficacy of chemotherapy for brain metastases from breast carcinoma: In regard to Le Scodan et al. (Int J Radia T Oncol Biol Phys 2007;69 : 839-845)
DİZDAR Ö., Tapan U., Altundag K.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
, cilt.70, sa.5, ss.1615, 2008 (SCI-Expanded, Scopus)
2008
2008174. Erectile dysfunction in successfully treated lymphoma patients
AKSOY S., HARPUTLUOĞLU H., KILIÇKAP S., DİNÇER M., DİZDAR Ö., AKDOĞAN B., et al.
SUPPORTIVE CARE IN CANCER
, cilt.16, sa.3, ss.291-297, 2008 (SCI-Expanded, Scopus)
2008
2008175. Familial chemosensitivity test: Can it be a predictive factor in the management of familial breast cancer?
DİZDAR Ö., Harputluoglu H., Altundag K.
BREAST
, cilt.17, sa.1, ss.5, 2008 (SCI-Expanded, Scopus)
2008
2008176. Dasatinib may also inhibit c-Kit in triple negative breast cancer cell lines
DİZDAR Ö., ŞENER DEDE D., Bulut N., Altundag K.
BREAST CANCER RESEARCH AND TREATMENT
, cilt.107, sa.2, ss.303, 2008 (SCI-Expanded, Scopus)
2008
2008177. Role of trastuzumab in patients with brain metastases from Her2 positive breast cancer
Bulut N., Harputluoglu H., Dizdar O., Altundag K.
JOURNAL OF NEURO-ONCOLOGY
, cilt.86, sa.2, ss.241, 2008 (SCI-Expanded, Scopus)
2007
2007178. Potential targeted therapy options in the management of basal cell subtype of breast carcinoma
Harputluoglu H., DİZDAR Ö., Altundag K.
HUMAN PATHOLOGY
, cilt.38, sa.12, ss.1869, 2007 (SCI-Expanded, Scopus)
2007
2007179. Efficacy of anastrozole on local recurrence in patients with favorable early breast cancer
DİZDAR Ö., Harputluoglu H., Altundag K.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
, cilt.69, sa.5, ss.1651, 2007 (SCI-Expanded, Scopus)
2007
2007180. Vitamin D intake and breast cancer risk in postmenopausal women
Dizdar O., Harputluoglu H., Altundag K.
ARCHIVES OF INTERNAL MEDICINE
, cilt.167, sa.22, ss.2532, 2007 (SCI-Expanded, Scopus)
2007
2007181. Demographic, clinical, and pathological characteristics of Turkish triple-negative breast cancer patients: single center experience
Aksoy S., Dizdar O., Harputluoglu H., Altundag K.
ANNALS OF ONCOLOGY
, cilt.18, sa.11, ss.1904-1906, 2007 (SCI-Expanded, Scopus)
2007
2007182. Bone mineral density in breast cancer patients with estrogen receptor-negative tumor
Dede D. S., Dizdar O., Harputluoglu H., Altundag K.
MATURITAS
, cilt.58, sa.3, ss.324, 2007 (SCI-Expanded, Scopus)
2007
2007183. Appropriate utilization of hospital beds in internal medicine: evaluation in a tertiary care hospital
Dizdar O., Karadag O., Kalyoncu U., Kurt M., ULGER Z., SARDAN Y. C., et al.
JOURNAL OF EVALUATION IN CLINICAL PRACTICE
, cilt.13, sa.3, ss.408-411, 2007 (SCI-Expanded, Scopus)
2007
2007184. Rituximab-induced viral infections in lymphoma patients
Aksoy S., Harputluoglu H., Kilickap S., Dede D. S., Dizdar O., Altundag K., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.25, sa.18, 2007 (SCI-Expanded, Scopus)
2007
2007185. Predictive factors for metastasis in patients (pts) with gastric cancer
Kilickap S., Dizdar O., Harputluoglu H., Aksoy S., YALÇIN S. S.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.25, sa.18, 2007 (SCI-Expanded, Scopus)
2007
2007186. Research for bleeding tendency in patients presenting with significant epistaxis
Dizdar O., Onal I. K., Ozakin E., Karakilic E., Karadag O., Kalyoncu U., et al.
BLOOD COAGULATION & FIBRINOLYSIS
, cilt.18, sa.1, ss.41-43, 2007 (SCI-Expanded, Scopus)
2007
2007187. Macrophage inflammatory protein-1 alpha: A link between innate immunity and familial mediterranean fever?
Dizdar O., Kalyoncu U., Karadag O., Akdogan A., Kiraz S., Ertenli I., et al.
CYTOKINE
, cilt.37, sa.1, ss.92-95, 2007 (SCI-Expanded, Scopus)
2007
2007188. Rituximab-related viral infections in lymphoma patients
Aksoy S., Harputluoglu H., Kilickap S., Dede D. S., Dizdar O., Altundag K., et al.
LEUKEMIA & LYMPHOMA
, cilt.48, sa.7, ss.1307-1312, 2007 (SCI-Expanded, Scopus)
2006
2006189. Mucosa associated lymphoid tissue lymphoma of the sub mandibular gland presenting with relapse in the lacrimal gland
KURT M., Shorbagi A., ALTUNDAĞ M. K., AKYÖN YILMAZ Y., DİZDAR Ö., GÜLLÜ İ. H.
Leukemia , cilt.47, ss.1982-1984, 2006 (SCI-Expanded)
2006
2006190. Coincidence of increased pulmonary artery pressure and patent septum foramen ovate in patients with solid tumors may have a propensity to develop central nervous system metastases
Harputluoglu H., Dizdar O., Altundag K.
MEDICAL HYPOTHESES
, cilt.67, sa.4, ss.996, 2006 (SCI-Expanded, Scopus)
2005
2005191. Posterior leukoencephalopathy after combination chemotherapy in a patient with lymphoma
Abali H., Eren O., Dizdar O., Karadag O., Erman M., Yilmaz A., et al.
LEUKEMIA & LYMPHOMA
, cilt.46, sa.12, ss.1825-1828, 2005 (SCI-Expanded, Scopus)
2005
2005192. Seropositive arthritis in chronic lymphocytic leukemia: a remark on B cell-mediated autoimmunity
Onal I., Ozcakar L., Dizdar O., Buyukasik Y., Dundar S.
RHEUMATOLOGY INTERNATIONAL
, cilt.25, sa.7, ss.569-570, 2005 (SCI-Expanded, Scopus)
2005
2005193. Orbital metastasis from adenocarcinoma of the colon
Dizdar O., Aksoy S., Kilickap S., Yalcin S.
SOUTHERN MEDICAL JOURNAL
, cilt.98, sa.8, ss.846-847, 2005 (SCI-Expanded, Scopus)
2005
2005194. Group B streptococcal facet joint arthritis - Case report
Dizdar O., Alyamac E., Onal I., Uzun O.
SPINE
, cilt.30, sa.14, 2005 (SCI-Expanded, Scopus)
2004
2004195. Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia
Dizdar O., Yurekli B., Purnak T., Aksu S., Haznedaroglu I.
ANNALS OF PHARMACOTHERAPY
, cilt.38, ss.1319-1320, 2004 (SCI-Expanded, Scopus)
2004
2004196. Membranoproliferative glomerulonephritis associated with type 1 diabetes mellitus and Hashimoto's thyroiditis
Dizdar O., Kahraman S., Genctoy G., Ertoy D., Arici M., Altun B., et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION
, cilt.19, sa.4, ss.988-989, 2004 (SCI-Expanded, Scopus)
2004
2004197. Obesity: an endocrine tumor?
Dizdar O., Alyamac E.
MEDICAL HYPOTHESES
, cilt.63, sa.5, ss.790-792, 2004 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2024
20241. Incidence of unexpected lymph node positivity and its prognostic impact in patients undergoing pulmonary metastasectomy
KUMBASAR U., DİZDAR Ö., UYSAL S., DİKMEN E., YALÇIN Ş.
14th International Gastrointestinal Cancer Conference, İstanbul, Türkiye, 28 Kasım 2024, (Özet Bildiri)
2023
20232. Comprehensive approach focusing on the molecular profile of a rare genodermatosis: Epidermodysplasia Verruciformis
ERKAN D. D., Akcin O., DURMAZ ÖZDİNÇ C. D., ATEŞ ÖZDEMİR D., GÜLERAY LAFCI N., DİZDAR Ö.
56th Annual Conference of the European-Society-of-Human-Genetics (ESHG), Glasgow, İngiltere, 10 - 13 Haziran 2023, ss.397, (Özet Bildiri)
2020
20203. Relationship between sarcopenia and anthracycline related cardiotoxicity in patients with cancer
Bas O., Erdemir A., Onur R., Guner G., Guven D. C., Aksu S., et al.
ESMO Virtual Congress, ELECTR NETWORK, 19 Eylül - 18 Ekim 2020, cilt.31, (Özet Bildiri)
2020
20204. Daily chemotherapy and treatment unit in the COVID-19 era: Lessons of the first 60 days
Aktas B. Y., Guven D. C., Degirmenciler R. F., Taban H., Aktepe O. H., Kertmen N., et al.
ESMO Virtual Congress, ELECTR NETWORK, 19 Eylül - 18 Ekim 2020, cilt.31, (Özet Bildiri)
2020
20205. Evaluation of early unplanned readmissions and predisposing factors in an oncology clinic
Guven D. C., Ceylan F., Cakir I. Y., Cesmeci E., Sayinalp B., Yesilyurt B., et al.
ESMO Virtual Congress, ELECTR NETWORK, 19 Eylül - 18 Ekim 2020, cilt.31, (Özet Bildiri)
2020
20206. Changes in the outpatient and inpatient clinic admissions during COVID-19 pandemic: Anticipating and mitigating risks for cancer patients
Guven D. C., Aktas B. Y., Aksun M. S., Ucgul E., Sahin T. K., Yildirim H. C., et al.
ESMO Virtual Congress, ELECTR NETWORK, 19 Eylül - 18 Ekim 2020, cilt.31, (Özet Bildiri)
2020
20207. Prognostic role of tumoral DNA damage repair protein expression in patients with resectable pancreatic cancer
Ceylan F., Guven D. C., Taban H., Aktepe O., Kilickap S., Turker A., et al.
ESMO Virtual Congress, ELECTR NETWORK, 19 Eylül - 18 Ekim 2020, cilt.31, (Özet Bildiri)
2019
20198. outcomes of patients with resected pancreatic ductal adenocarcinoma
ceylan f., GÜVEN D. C., çakır y., Hamaloglu E., Karakoc D., TÜRKER F. A., et al.
9th international gastrointestinal cancer conference, 6 - 08 Aralık 2019, (Tam Metin Bildiri)
2019
20199. Embedded outpatient palliative care service within the oncology clinic: Preliminary experience in Hacettepe Oncology Hospital
Guven D. C., AKTEPE O. H., Berk Z., Guner G., Taban H., AKTAŞ B. Y., et al.
44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, İspanya, 27 Eylül - 01 Ekim 2019, cilt.30, (Özet Bildiri)
2019
201910. Clinicopathologic features of BRCA mutated breast cancer patients: Hacettepe experience
AKSOY S., DEĞİRMENCİLER R. F., AKTAŞ B. Y., Guven D. C., AKTEPE O. H., Guner G., et al.
44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, İspanya, 27 Eylül - 01 Ekim 2019, cilt.30, (Özet Bildiri)
2019
201911. MAY CANCER RISK BE DECREASED IN A LARGE COHORT OF CHILD AND ADULT FAMILIAL MEDITERRANEAN FEVER PATIENTS?
BİLGİN E., GÜVEN D. C., Ceylan S., AYBI ÖZDEMİR Ö., KARDAŞ R. C., FIRLATAN B., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.993, (Özet Bildiri)
2019
201912. Effectiveness and safety of ferric carboxymaltose to treat iron deficiency anemia in cancer patients.
Aktas B. Y., Kayku V. E., Aslan A., Kertmen N., Dizdar Ö., Yalcin S., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2019, cilt.37, (Özet Bildiri)
2019
201913. Clinical features and prognosis of patients with liposarcoma: Single-center experience.
Demir M., Guven D. C., Aktas B. Y., Guner G., Aktepe O. H., Taban H., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2019, cilt.37, (Özet Bildiri)
2018
201814. TRANSCULTURAL ADAPTATION OF EORTC-QLQ-CR29 SCALE INTO TURKISH, AND ASSESSMENT OF VALIDITY ANDRELIABILITY IN TURKISH PATIENTS WITH COLORECTAL CANCER
HAYRAN K. M., YÜCE D., KILIÇKAP S., houssein b., ERMAN M., DİZDAR Ö., et al.
ISPOR Asia Pacific 2018, Tokyo, Japonya, 8 - 11 Kasım 2018, cilt.1, ss.11, (Tam Metin Bildiri)
2018
201815. EFFECTS OF CANCER TYPES ON LOCAL AND OUT-OF-CITY ADMISSIONS FOR MEDICAL CARE
HAYRAN K. M., YÜCE D., KILIÇKAP S., DİZDAR Ö., houssein b., ERMAN M., et al.
ISPOR Asia Pacific 2018, Tokyo, Japonya, 8 - 11 Kasım 2018, (Özet Bildiri)
2018
201816. Kolorektal Kanserde 16S rDNA Sekanslama ile Oral Mikrobiyom Analizi
GÜVEN D. C., ERGÜNAY K., BRİNKMANN A., ALP A., AKDOĞAN KITTANA F. N., AKYÖN YILMAZ Y., et al.
2. Ulusal immünoterapi ve Onkoloji Kongresi, Antalya, Türkiye, 31 Ekim - 04 Kasım 2018, (Tam Metin Bildiri)
2018
201817. Compliance to the guideline of diagnostic tests in febrile neutropenic patients at a Turkish university hospital’
ZARAKOLU KÖŞKER I. P., AKOVA M., BÜYÜKAŞIK Y., DURUSU TANRIÖVER M., DİZDAR Ö., METAN G., et al.
20th Symposium on Infections in the immunocompromised host, Atina, Yunanistan, 17 - 19 Haziran 2018, (Tam Metin Bildiri)
2018
201818. Analysis of Fusobacterium nucleatum, Streptococcus gallolyticus and Porphyromonas gingivalis in saliva in colorektal patients and healty controls. Abst ID:”e15117”
GÜVEN D. C., DİZDAR Ö., ALP A., Akdoğan Kittana F. N., KARAKOÇ D., Hamaloğlu E., et al.
2018 ASCO, Chicago, Amerika Birleşik Devletleri, 1 - 05 Haziran 2018, (Özet Bildiri)
2018
201819. Evaluation of cancer risk in patients with periodontal diseases.
GÜVEN D. C., DİZDAR Ö., AKMAN A. C., BERKER A. E., YEKEDÜZ E., CEYLAN F., et al.
2018 ASCO Annual Meeting, Chicago, Amerika Birleşik Devletleri, 1 - 05 Haziran 2018, cilt.36, ss.13571, (Özet Bildiri)
2018
201820. Kolorektal Kanserli Hastalarda Ve Sağlıklı Kontrollerde Tükürükte Fusobacterium Nucleatum, Streptococcus Gallolyticus Ve Porphyromonas Gingivalis Analizi
GÜVEN D. C., DİZDAR Ö., ALP A., AKDOĞAN KITTANA F. N., KARAKOÇ D., HAMALOĞLU E., et al.
7. Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 21 - 25 Mart 2018, (Özet Bildiri)
2017
201721. Multimodality treatment in malignant peripheral nerve sheath tumors
KARAKAŞ Y., DİZDAR Ö., KÖSEMEHMETOĞLU K., GEDİKOĞLU M. G., SÖYLEMEZOĞLU A. F., BOZBULUT U. B., et al.
International Congress on oncological sciences, 28 Eylül - 01 Ekim 2017, (Özet Bildiri)
2017
201722. Using Taylor Regression to Identify Points of Cahnge in Local Cancer Trends
HAYRAN K. M., YÜCE D., DİZDAR Ö.
GAP 2017 CONFERENCE, 9 - 11 Mayıs 2017, (Özet Bildiri)
2017
201723. SEVERE PERIODONTITIS IS ASSOCIATED WITH INCREASED CANCER RISK
DİZDAR Ö., HAYRAN K. M., GÜVEN D. C., Yılmaz T. B., Taheri S., AKMAN A. C., et al.
GAP 2017 Conference, Texas, Amerika Birleşik Devletleri, 9 - 11 Mayıs 2017, (Özet Bildiri)
2017
201724. Smoker relatives of inpatients: A reasonable but heterogeneous target population for smoking cessation program
AKTAŞ B. Y., HOUSSEİN b., YÜCE D., DİZDAR Ö., KILIÇKAP S., ERMAN M., et al.
7th ECTOH Conference on Tobacco or Health, Porto, Portekiz, 22 - 25 Mart 2017, (Özet Bildiri)
2016
201625. Evaluating Admissions of Foreign Patients to a University Hospital in Turkey
HAYRAN K. M., YÜCE D., DENEK S., DİZDAR Ö.
International Forum for Quality Cancer Care, 27 - 29 Ekim 2016, (Tam Metin Bildiri)
2016
201626. Using geographical information systems to describe quality of life as a function of distance in cancer patients
HAYRAN K. M., ERMAN M., KILIÇKAP S., DİZDAR Ö., YÜCE D., HÜSEYİN B., et al.
ISPOR Asia Pacific Meeting 2016, 3 - 06 Eylül 2016, cilt.19, ss.892, (Özet Bildiri)
2016
201627. The impact of the total size of lesions in multifocal multicentric breast cancer on survival
Karakaş Y., DİZDAR Ö., Akın S., ATEŞ Ö., ŞENDUR M. A. N., AKSOY S., et al.
2016 ASCO Annual Meeting, 29 Mayıs - 03 Haziran 2016, (Tam Metin Bildiri)
2016
201628. Intravenous ferric carboxymaltose treatment in cancer patients
ASLAN A., TAŞDEMİR V., KERTMEN N., DİZDAR Ö., AKSOY S.
2016 ASCO Annual Meeting, 29 Mayıs - 03 Haziran 2016, (Tam Metin Bildiri)
2016
201629. Clinicopathologic characteristics of patients with recurrent or metastatic synovial sarcoma
ATEŞ Ö., AKSOY S., YETER H. H., Akın S., KERTMEN N., DİZDAR Ö., et al.
2016 ASCO Annual Meeting, 29 Mayıs - 03 Haziran 2016, (Tam Metin Bildiri)
2015
201530. Pleomorphic lobular carcinoma of the breast associated with impaired overall survival
Hacioglu M. B., Babacan T., Diker O., Akin S., Demir M., Dizdar O., et al.
European Cancer Congress, Vienna, Avusturya, 01 Ocak 2015, cilt.51, (Özet Bildiri)
2015
201531. Neuroendocrine breast cancer A single center experience
TAŞDEMİR V., Kertmen N., CENOLİ A., KESKİN Ö., KARAKAS Y., Diker Ö., et al.
2015 ASCO Annual Meeting, 29 Mayıs - 02 Haziran 2015, (Tam Metin Bildiri)
2015
201532. Cytoreductive surgery for intestinal cancer patients metastatic to the adnexal presenting as primary ovarian cancer.
Arik Z., Dizdar O., Yildirim M. E., Ozgu E., Oz M., Terzioglu S. G., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)
2015
201533. Correlation of histopahologic response and prognostic markers with survival in locally advanced non-small cell lung cancer patients who have treated with neoadjuvant chemotherapy.
Kucukoztas N., Oguz A., Rahatli S., Dizdar O., Keskin G. S. Y., Ozyilkan O., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)
2015
201534. Signet ring cell carcinoma of breast: Single center experience.
AKIN S., DIKER O., KERTMEN N., ATEŞ Ö., DİZDAR Ö., YALÇIN Ş., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)
2014
201435. Response rates of taxane rechallenge in metastatic breast cancer patients, previously treated with adjuvant taxanes.
Oguz A., Babacan T., Dizdar O., Kucukoztas N., Rahatli S., Keskin G. S. Y., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)
2014
201436. Is there any correlation between molecular subtypes and blood groups in breast cancer?
Kucukoztas N., Oguz A., Babacan T., Dizdar O., Rahatli S., Sarici S. F., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)
2013
201337. Outcomes of patients with endometrial cancer and aggressive histology.
Rahatli S., Kucukoztas N., Dizdar O., Dursun P., Yalcin S., Haberal N., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)
2013
201338. Impact of treatment strategies on local control and survival in uterine carcinosarcomas.
Yalcin S., Dizdar O., Kucukoztas N., Rahatli S., Ozen O., Dursun P., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)
2013
201339. Impact of comorbidities on recurrence rates and survival in patients with endometrial cancer.
Kucukoztas N., Dizdar O., Rahatli S., Tarhan C., Haberal N., Dursun P., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)
2012
201240. Retrospective analysis of stage IIIc uterine carcinoma patients: A single center experience.
Yalcin S., Rahatli S., Kucukoztas N., Ozen O., Haberal N., Tarhan C., et al.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30, (Özet Bildiri)
2012
201241. Outcome of breast cancer patients with stage I diesease: A retrospective analysis
Ergun A., Kucukoztas N., Yalcin S., Rahatli S., Babacan T., Yagmurdur M. C., et al.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30, (Özet Bildiri)
2012
201242. Retrospective analysis of octagenarian breast cancer patients: Multicenter retrospective study.
Dizdar O., Arslan C., Eren T., Yalcin S., Kucukoztas N., Aksoy S., et al.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30, (Özet Bildiri)
2012
201243. Retrospective analysis of stage IC uterine cancer patients: A single center experience.
Kucukoztas N., Yalcin S., Rahatli S., Ozen O., Haberal N., Tarhan C., et al.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30, (Özet Bildiri)
2009
200944. The Frequency and Determinants of Metabolic Syndrome in Patients with Operable Stage I-III Breast Cancer.
Aksoy S., Dizdar O., Dede D. S., Arslan C., Dogan E., Tapan U., et al.
32nd Annual San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 9 - 13 Aralık 2009, cilt.69, (Özet Bildiri)
2009
200945. Comparison of serum levels of CEA and CA 15-3 in triple-negative breast cancer at the time of metastases and serum levels at the time of first diagnosis
Dede D. S., Aksoy S., Bulut N., Dizdar O., Arik Z., Gullu I., et al.
45th Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2009, cilt.27, (Özet Bildiri)
2009
200946. Zoledronic acid and atrial fibrillation in cancer patients with bone metastases
Aksoy S., Dizdar O., Turgut D., Dede D. S., Arslan C., Harputluoglu H., et al.
45th Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2009, cilt.27, (Özet Bildiri)
2007
200747. Characteristics of breast cancer patients with central nervous system metastases and factors associated with survival after development of central nervous system metastasis
Harputluoglu H., Dizdar O., Aksoy S., Kilickap S., Dede D. S., Ozisik Y., et al.
30th Annual San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 13 - 16 Aralık 2007, cilt.106, (Özet Bildiri)
2005
200548. The correlations of plasma inflammatory markers and anti-nucleosome antibodies with SLEDAI
Kalyoncu U., Akdogan A., Calguneri M., Karadag O., Kisacik B., Apras S., et al.
Annual European Congress of Rheumatology, Vienna, Avusturya, 8 - 11 Haziran 2005, cilt.64, ss.237, (Özet Bildiri)
2005
200549. Biochemical markers of bone turnover in the diagnosis of myeloma bone disease.
Dizdar O., Barista I., Kalyoncu U., Karadag O., Celik I., Kars A., et al.
41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, Amerika Birleşik Devletleri, 13 - 17 Mayıs 2005, cilt.23, (Özet Bildiri)
2003
200350. What does determine homocysteine levels in hemodialysis patients: Nutrition or inflammation?
Kahraman S., Genctoy G., Yilmaz R., Dizdar O., Arici M., Altun B., et al.
36th Annual Meeting of the American-Society-of-Nephrology, SAN DIEGO, CALIFORNIA, 12 - 17 Kasım 2003, cilt.14, (Özet Bildiri)
Kitaplar
2019
20191. Nutrition and Cachexia in Gastrointestinal Cancer Patients
HALİL M. G., Kuyumcu M. E., DİZDAR Ö., ÜLGER Z., YALÇIN Ş.
Textbook of Gastrointestinal Oncology, Yalçın Şuayib, Philip A. Philip, Editör, Springer, ss.379-394, 2019
2019
20192. esophaeal and gastroesophaeal junction tumors
YALÇIN Ş., DİZDAR Ö., KILIÇKAP S., cilbir e., philip p. a.
textbook of gastrointestinal oncology, Suayib Yalcin, Philip a. Philip, Editör, springer, ss.55-72, 2019
Desteklenen Projeler
2021 - 2022
2021 - 2022
COVID19 aşısı uygulanan kanser hastalarında aşının etkinliğinin COVID19 antikor düzeyi ölçülerek değerlendirilmesi
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
DİZDAR Ö. (Yürütücü), ÜNAL S., GÜVEN D. C., GÜLBAHÇE İNCESU F. G., HAYRAN K. M., ERMAN M., et al.
2019 - 2022
2019 - 2022
İmmün Kontrol Noktası Blokaj Tedavisi Alması Planlanan Kanser Hastalarında Tedavi Yanıtının Genetik Ve İmmünolojik Belirleyicilerinin Araştırılması
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
DİZDAR Ö. (Yürütücü), DEMİRKOL CANLI S., GÜVEN D. C., ULUSOY S., ESENDAĞLI G., ERMAN M., et al.
2019 - 2020
2019 - 2020
Pankreas kanserli hastalarda tümörde BRCA1 BRCA2 ve ATM ekspresyonunun kemoterapi yanıtı ve sağ kalım ile ilişkisinin değerlendirilmesi
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
DİZDAR Ö. (Yürütücü), Ceylan F., AKYOL A.
2017 - 2018
2017 - 2018
Kolon kanseri ile tükürük mikrobiyom ilişkisi
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
DİZDAR Ö. (Yürütücü), Güven D. C., AKDOĞAN KITTANA F. N., ALP A.
2017 - 2017
2017 - 2017
"The University of Texas MD Anderson Cancer Center,
Global Academic Programs GAP 2017 Conference May 9-11, 2017, Houston, USA" kongresine katılım
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
DİZDAR Ö. (Yürütücü)
2015 - 2016
2015 - 2016
11. Hacettepe Üniversitesi Kanser Enstitüsü Onkoloji Sempozyumu
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
ÖZMEN F. (Yürütücü), ÖZYİĞİT G., DİZDAR Ö.